JWJia-Ying Wang

Jia-Ying Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jia-Ying Wang has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Hongcai Shang

    Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China

    1 shared publication
  • Jing Chen

    Baokang Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China

    1 shared publication
  • Jingbo Zhai

    School of Public Health, Tianjin University of Traditional Chinese Medicine, Tianjin, China

    1 shared publication
  • Jingyuan Mao

    First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China

    1 shared publication
  • Lu Xiao

    The Center of Evidence Based Medicine, Tianjin University of Traditional Chinese Medicine, Anshan West Road, Tianjin 300193, China

    1 shared publication
  • Wei Mu

    Department of Clinical Pharmacology, The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, 300150, China

    1 shared publication

Latest Publications

  • Open Access

    Potential effectiveness of traditional Chinese medicine for cardiac syndrome X (CSX): a systematic review and meta-analysis

    by Jia-Ying Wang, Lu Xiao, Jing Chen, Jing-Bo Zhai, Wei Mu, Jing-Yuan Mao, Hongcai Shang

    Background: Treatment of cardiac syndrome X with unknown pathological mechanism remains a big challenge for clinicians. Complementary and alternative medicine may bring a new choice for its management. The aim of this study is to evaluate the clinical effects of traditional Chinese medicine on cardiac syndrome X patients. Methods: We systematically searched databases such as Cochrane CENTRAL, PubMed, EMBASE, CBM, Chinese National Knowledge Infrastructure (CNKI), WanFang and VIP, and handsearched relevant journals to identify randomized controlled trials. Following the steps of systematic review recommended by the Cochrane group, we assessed the quality of included studies, extracted valid data and undertook meta-analysis. Results: Twenty one moderate-to low-quality randomized controlled trials involving 1143 patients were included. The results showed that traditional Chinese medicine could improve angina [OR=1.34, 95% CI: 1.2 to 1.50], electrocardiogram (ECG), endothelin-1 (ET-1) levels, prolong exercise duration in treadmill tests, and reduce angina frequency per week compared with routine treatment. No other side effect was reported except two cases of stomach pain. Conclusion: Compared with conventional treatment, traditional Chinese medicine shows the potential of optimizing symptomatic outcomes and improving ECG and exercise duration. The efficacy of TCM may find explanation in its pharmacological activity of adjusting the endothelial function. TCM, as a kind of alternative and complementary medicine, may provide another choice for CSX patients.